MD, MSc PH
Emmanuelle was trained in France as a GP and in Infectious and Tropical diseases. She has worked in diverse organisations in France, French Guiana and sub-Saharan Africa as a clinician and in HIV clinical trials. After a MSc PH at the London School of Hygiene and Tropical Medicine, she enrolled in a Public Health PhD program at the French Institute of Medical Research (Inserm) focusing on the evaluation of health care interventions and shared decision-making. Her main clinical and scientific interests are the care of people living with HIV, particularly antiretroviral therapy optimisation and co-infections (including COVID-19).
Emmanuelle is working in TVRP on D2EFT, COHIVE and other projects in the treatment of HIV and its co-morbidities.
Emmanuelle is currently involved in D2EFT study (NCT03017872) and is the protocol lead investigator for D2EFT-GIC (NCT04668443) and COHIVE (NCT04371835). She is also an investigator in CORIA (NCT04354818).